Last update 21 Nov 2024
Tetravalent influenza vaccine(Split)(Jiangsu Walvax )
Last update 21 Nov 2024
Overview
Basic Info
Drug Type Prophylactic vaccine, Multivalent vaccine |
Synonyms 四价流感病毒裂解疫苗（江苏沃森） |
Target- |
Mechanism Immunostimulants |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
Drug Highest PhasePhase 3 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
3
Clinical Trials associated with Tetravalent influenza vaccine(Split)(Jiangsu Walvax )评价4价流感病毒裂解疫苗在3岁及以上人群中接种的安全性和免疫原性的随机、盲法、阳性对照III期临床试验
[Translation] A randomized, blinded, positive-controlled phase III clinical trial to evaluate the safety and immunogenicity of a 4-valent influenza virus split vaccine in people aged 3 years and above
评价4价流感病毒裂解疫苗用于6~35月龄、3岁及以上健康人群安全性的开放式Ⅰ期临床试验
[Translation] An open phase I clinical trial to evaluate the safety of a quadrivalent influenza virus split vaccine in healthy people aged 6 to 35 months and 3 years and above
AN OPEN-LABEL, SINGLE-TREATMENT, SINGLE-PERIOD, SINGLE DOSE, CLINICAL PHASE 1 STUDY TO ASSESS THE SAFETY AND TOLERABILITY OF INACTIVATED TETRAVALENT INFLUENZA VACCINE (SPLIT VIRION) OF M/s CADILA HEALTHCARE LTD., INDIA IN HEALTHY, ADULT, MALE, HUMAN SUBJECTS. - NA
100 Clinical Results associated with Tetravalent influenza vaccine(Split)(Jiangsu Walvax )
Login to view more data
100 Translational Medicine associated with Tetravalent influenza vaccine(Split)(Jiangsu Walvax )
Login to view more data
100 Patents (Medical) associated with Tetravalent influenza vaccine(Split)(Jiangsu Walvax )
Login to view more data
100 Deals associated with Tetravalent influenza vaccine(Split)(Jiangsu Walvax )
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Influenza, Human | Phase 3 | CN | 31 Oct 2024 | |
| Acute respiratory disease | Phase 3 | CN | 14 Oct 2024 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free